Technology News and Research

RSS

Magellan, ACG partner to train specialists to provide Peer Support Whole Health services

Magellan Health Services, Inc., an industry leader in behavioral health care management, and Appalachian Consulting Group (ACG) have joined forces to train peer specialists to provide Peer Support Whole Health (PSWH) services. PSWH, an evidence-based behavioral health practice that is growing in use across the country, focuses on improving the overall physical and mental health of individuals with mental illnesses to help them achieve their health and wellness goals.

21 Dec 2010

Touro University Worldwide introduces new online program in Marriage and Family Therapy

Dr. Bernard Luskin, CEO and Senior Provost of Touro University Worldwide recently announced its new online program in Marriage and Family Therapy with concentrations in pastoral counseling, coaching, mediation and dispute resolution.

21 Dec 2010

Silence provides year-end update on trading and offer-period

Silence Therapeutics plc, a leading global biotechnology company dedicated to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases, today provides a year-end update on trading and the offer-period.

21 Dec 2010

Ovarian cancer tissue and healthy tissue smell different

György Horvath from the University of Gothenburg, Sweden, and researchers from the University of Gävle and KTH Royal Institute of Technology have been able to confirm in tests that ovarian cancer tissue and healthy tissue smell different. The results were published recently in the journal Future Oncology.

21 Dec 2010

Lilly Endowment grants funds to Manchester College to establish School of Pharmacy

A small Midwest college that is producing alumni with sizeable reputations in the science world has received a $35 million grant from Lilly Endowment to launch a School of Pharmacy.

21 Dec 2010

Royal DSM to acquire Martek for $1,087 million

Royal DSM N.V., the global Life Sciences and Materials Sciences company, and Martek Biosciences Corporation today announce that they have entered into a definitive agreement under which DSM will acquire all the outstanding shares of common stock of Martek for US$31.50 in cash per share for total consideration of US$1,087 million.

21 Dec 2010

New CPT code for use with T-SPOT.TB test

Oxford Immunotec, Inc. announces that a new and specific Current Procedural Terminology (CPT®) code has been established by the American Medical Association for use with the T-SPOT®.TB test. The new Category I code, 86481, is described as "Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension." This new code will be effective as of January 1, 2011.

21 Dec 2010

Diopsys develops new SD-OCT imaging software for ophthalmologists

Diopsys, today announced the development of software that uses existing Spectral Domain Optical Coherence Tomography images to assist ophthalmologists and optometrists in diagnosing retinal and optic nerve disease such as glaucoma.

21 Dec 2010

Researchers develop new lung imaging technique that causes minimum tissue disruption

Fast-moving objects create blurry images in photography, and the same challenge exists when scientists observe cellular interactions within tissues constantly in motion, such as the breathing lung. In a recent UCSF-led study in mice, researchers developed a method to stabilize living lung tissue for imaging without disrupting the normal function of the organ.

21 Dec 2010

Biogen Idec acquires Neurimmune subsidiary

Biogen Idec and Neurimmune Holding AG today announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to three pre-clinical immunotherapy programs. The three programs are focused on the discovery and development of novel human antibodies that address three central nervous system (CNS) targets: alpha-synuclein, tau and TDP-43.

21 Dec 2010

Researchers show how malaria parasites infect red blood cells, impede blood flow to organs

Although the incidence of malaria has declined in all but a few countries worldwide, according to a World Health Organization report earlier this month, malaria remains a global threat. Nearly 800,000 people succumbed to the mosquito-borne disease in 2009, nearly all of them in the developing world.

21 Dec 2010

VistaGen reports successful completion of AV-101 Phase 1 safety study for neuropathic pain

VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety study of AV-101, the Company's novel orally available prodrug candidate for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S.

20 Dec 2010

DNA tunneling detector embedded in a ‘Nanopore’

Scientists from Imperial College London are developing technology that could ultimately sequence a person's genome in mere minutes, at a fraction of the cost of current commercial techniques.

20 Dec 2010

Criterions EHR earns ONC-ATCB 2011/2012 certification

Criterions EHR has received the federal government's "meaningful use" stamp of approval by earning Complete EHR Ambulatory certification. The designation officially deems the electronic health record (EHR) software capable of enabling providers to qualify for funding under the American Recovery and Reinvestment Act (ARRA).

20 Dec 2010

HistoRx grants Metamark worldwide license to AQUA technology for commercialization of Prognostic Assays

Metamark Genetics, Inc., a privately held oncology-focused molecular diagnostics company, and HistoRx, Inc., a diagnostics company developing tissue-based diagnostic solutions to advance individualized patient care, today announced a multi-year licensing agreement. HistoRx has granted Metamark a worldwide license to the AQUA technology for the clinical commercialization of Metamark's proprietary MetamarkDx™ Prognostic Assays.

20 Dec 2010

Opsens unveils EasyWire for growth market of Fractional Flow Reserve for coronary lesion assessment

Opsens Inc. today unveiled the EasyWire, developed by its medical division for the growth market of Fractional Flow Reserve for coronary lesion assessment.

20 Dec 2010

Itamar Medical, Roche enter development agreement for EndoPAT device

Itamar Medical, the leader in non-invasive vascular health diagnostics, announced today that an agreement has been signed with Roche by which Itamar will develop an EndoPAT device designated for use with animal models, enabling pre-clinical studies examining the efficacy of various compounds in the early stage of drug development essential for later stage development in humans.

20 Dec 2010

NanoLogix enters collaboration with Advanced Medical German Company of Kuwait

NanoLogix, an innovator in the accelerated detection and identification of microorganisms, is pleased to announce its collaboration with Advanced Medical German Company of Kuwait (AMGKWT). This alliance will support NanoLogix's market penetration goals for the Middle East, North and East Africa with the international marketing focus of Advanced Medical German Company stretching from the Middle East through Africa.

20 Dec 2010

King submits ACUROX NDA to FDA

King Pharmaceuticals®, Inc. and Acura Pharmaceuticals, Inc. today announced that King has submitted a New Drug Application (NDA) for ACUROX® (oxycodone HCl) Tablets to the U.S. Food and Drug Administration (FDA), including a request for priority review classification. ACUROX® is an immediate release tablet containing oxycodone HCl intended for the relief of moderate to severe pain.

20 Dec 2010

Arrowhead launches new company, Ablaris to commercialize novel weight loss technology

Arrowhead Research Corporation today announced that it has executed an exclusive world-wide license on technology developed by Drs. Wadih Arap and Renata Pasqualini at MD Anderson Cancer Center for use in weight loss and obesity-related metabolic conditions, and that it has launched a new company, Ablaris Therapeutics Inc., to commercialize this platform.

20 Dec 2010

Technology News and Research

Magellan, ACG partner to train specialists to provide Peer Support Whole Health services

Touro University Worldwide introduces new online program in Marriage and Family Therapy

Silence provides year-end update on trading and offer-period

Ovarian cancer tissue and healthy tissue smell different

Lilly Endowment grants funds to Manchester College to establish School of Pharmacy

Royal DSM to acquire Martek for $1,087 million

New CPT code for use with T-SPOT.TB test

Diopsys develops new SD-OCT imaging software for ophthalmologists

Researchers develop new lung imaging technique that causes minimum tissue disruption

Biogen Idec acquires Neurimmune subsidiary

Researchers show how malaria parasites infect red blood cells, impede blood flow to organs

VistaGen reports successful completion of AV-101 Phase 1 safety study for neuropathic pain

DNA tunneling detector embedded in a ‘Nanopore’

Criterions EHR earns ONC-ATCB 2011/2012 certification

HistoRx grants Metamark worldwide license to AQUA technology for commercialization of Prognostic Assays

Opsens unveils EasyWire for growth market of Fractional Flow Reserve for coronary lesion assessment

Itamar Medical, Roche enter development agreement for EndoPAT device

NanoLogix enters collaboration with Advanced Medical German Company of Kuwait

King submits ACUROX NDA to FDA

Arrowhead launches new company, Ablaris to commercialize novel weight loss technology

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News